06 November 2017: Short Communications
Is Kidney Donor Profile Index (KDPI) Valid for Hepatitis C Aviremic Kidneys?
Lena Sibulesky A 1*, Catherine E. Kling E 1, Ajit P. Limaye E 2, Christopher K. Johnson E 3
DOI: 10.12659/AOT.905428
Ann Transplant 2017; 22:663-664
Abstract
ABSTRACT: The Kidney Donor Risk Index (KDRI) and Kidney Donor Profile Index (KDPI) assist clinicians with the selection of deceased donor kidneys. This scoring system is based on 10 donor factors including Hepatitis C virus (HCV) status from serological or NAT testing. The donor HCV status (i.e., having either a positive hepatitis C antibody (Ab) or nucleic acid testing (NAT) result) increases the hazard ratio for graft failure by 1.27 and the KDPI by approximately 20%. Whether this increase in KDPI is a true reflection of graft quality for HCV seropositive but not viremic donors is unknown. Further investigations are needed to maximize the use of these organs.
Keywords: Hepatitis C Antibodies, Tissue and Organ Procurement, Tissue Donors
References
1. Israni AK, Salkowski N, Gustafson S, New national allocation policy for deceased donor kidneys in the United States and possible effect on patient outcomes: J Am Soc Nephrol, 2014; 25(8); 1842-48, pmid: 24833128
2. Rao PS, Schaubel DE, Guidinger MK, A comprehensive risk quantification score for deceased donor kidneys: The kidney donor risk index: Transplantation, 2009; 88(2); 231-36, pmid: 19623019
3. Abbott KC, Bucci JR, Matsumoto CS, Hepatitis C and renal transplantation in the era of modern immunosuppression: J Am Soc Nephrol, 2003; 14(11); 2908-18, pmid: 14569101
4. , UNet System Notice – Upcoming Waitlist and and DonorNet changes will reflect policy changes regarding infectious diseases screening [Internet]: UNOS System Notices - General Notice, 2017 [cited 16 March 2017]. Available from:https://portal.unos.org/ViewSystemNotice.aspx?id=3074
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






